Vos, P A J M <br/><br/>
Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.  [electronic resource] 

 -  Rheumatology (Oxford, England)  May 2006 
 - 629-35 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1462-0324 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kei260  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Antinuclear--blood<br/>Autoimmune Diseases--diagnosis<br/>Biomarkers--blood<br/>Child<br/>Child, Preschool<br/>Cost-Benefit Analysis<br/>DNA--immunology<br/>Fluorescent Antibody Technique, Indirect--economics<br/>Health Care Costs--statistics & numerical data<br/>Humans<br/>Immunoassay--economics<br/>Infant<br/>Middle Aged<br/>Netherlands<br/>Reproducibility of Results<br/>Sensitivity and Specificity